Table 2. Indications for DEM-TACE.

Intermediate stage patients, BCLC-B (asymptomatic, multinodular tumors without vascular invasion or extrahepatic spread)

Patients indicated for curative treatment but not eligible for this treatment

Disease recurrence after curative treatment

Extending period during which patient fulfills criteria for liver transplantation

Downstaging disease to fulfill criteria for liver transplantation

Patients indicated for c-TACE but with cardiac failure or expected to have severe post-embolic toxicity

BCLC = Barcelona Clinic Liver Cancer, c-TACE = conventional transcatheter arterial chemoembolization, DEM-TACE = drug-eluting microsphere transcatheter arterial chemoembolization